Best of the year: Advanced breast cancer in 2023.

Authors:
Schlam I; Chavez-MacGregor M.

Journal:
Breast

Publication Year: 2024

DOI:
10.1016/j.breast.2024.103677

PMCID:
PMC10901908

PMID:
38401422

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Breast

Abbreviation: Breast

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
21-gene recurrence score in predicting the outcome of postoperative radiotherapy in T1-2N1 luminal …
Xie SJ; Wang RJ; Wu SG and 1 more (2024) - Transparency Score: 3/6
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clin…
Guo X; Zhang J; Gong X and 24 more (2024) - Transparency Score: 3/6
"Heterogeneity of treatment effect on patients' long-term outcome according to pathological respons…
Pala L; Sala I; Pagan E and 11 more (2024) - Transparency Score: 3/6
Interactive multidisciplinary pilot workshop to improve medical student perception of and interest …
Raheel A; Dalla S; Birney J and 8 more (2024) - Transparency Score: 3/6
Local hero: A phase II study of local therapy only (stereotactic radiosurgery and / or surgery) for…
Phillips C; Pinkham MB; Moore A and 6 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest Mariana Chavez-MacGregor: Consultant/Advisory Board: Pfizer, Novartis, Astra Zeneca, Lilly, Genentech/Roche, Exact Sciences, Merck, Daiichi-Sankyo. Data Safety Monitoring Committee: Astra Zeneca, Genentech/Roche. Ilana Schlam: Nothing to disclose."

Evidence found in paper:

"Funding sources Mariana Chavez-MacGregor is supported by Susan G. Komen (SAC220221) and the Breast Cancer Research Foundation (BCRF-22-190, BCRF-23-190)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025